Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




"Homer Simpson” Gene Found to Limit Learning in Mice

By LabMedica International staff writers
Posted on 13 Oct 2010
Deleting a specific gene in lab mice was shown to make them more intelligent by unlocking an elusive area of the brain believed to be comparatively inflexible. More...
Mice with a disabled RGS14 gene are able to remember objects they had explored and learn to navigate mazes better than the control study mice, suggesting that RGS14's presence limits some forms of learning and memory.

The study's findings were published online September 2010 in the Early Edition of the Proceedings of the [U.S.] National Academy of Sciences (PNAS). Since RGS14 appears to hold mice back mentally, John Hepler, Ph.D., a professor of pharmacology at Emory University School of Medicine (Atlanta, GA, USA), reported that he and his colleagues have been teasingly calling it the "Homer Simpson gene.”

RGS14 is principally switched on in one specific part--called CA2--of the hippocampus, a region of the brain known for decades to be involved in integrating new learning and forming new memories. However, the CA2 region lies off the general path scientifically and it is not clear what its functions are, according to Dr. Hepler. RGS14, which is also found in humans, was identified more than a decade ago. Dr. Hepler and his colleagues have previously shown that the RGS14 protein can regulate several molecules involved in processing different types of signals in the brain that are known to be important for learning and memory. They believe RGS14 is a key control protein for these signals.

To determine RGS14's functions better, Sarah Emerson Lee, a graduate student working with Dr. Hepler, characterized mice whose RGS14 genes were disabled using gene-targeting technology. In collaboration with Serena Dudek, Ph.D., at the U.S. National Institute of Environmental Health Sciences (Bethesda, MD, USA), they evaluated how the CA2 region responded to electrical stimulation in the gene-altered mice.

Many researchers have examined how other areas of the hippocampus are involved in long-term potentiation, a strengthening of connections between neurons that can be seen after new memory formation or artificial stimulation in a culture dish. The CA2 region is distinct from other regions for being resistant to long-term potentiation, and neurons within CA2 are able to survive injury by seizures or stroke more than neurons in other parts of the hippocampus.

The researchers were amazed to find that, in mice with a disabled RGS14 gene, the CA2 region was now capable of "robust” long-term potentiation, meaning that in response to electrical stimulation, neurons there had stronger connections. Moreover, the ability of the gene-altered mice to recognize objects previously placed in their cages was enhanced, compared to normal mice. They also learned more quickly to navigate through a water maze to a concealed escape platform by remembering visual cues.

"A big question this research raises is why would we, or mice, have a gene that makes us less smart--a Homer Simpson gene?” Dr. Hepler remarked. "I believe that we are not really seeing the full picture. RGS14 may be a key control gene in a part of the brain that, when missing or disabled, knocks brain signals important for learning and memory out of balance.”

The absence of RGS14 does not seem to hurt the modified mice, but it is still possible that they have their brain functions altered in a manner that researchers have not yet been able to spot. In addition to being resistant to injury by seizure, certain types of CA2 neurons are lost in schizophrenia, and loss of another gene turned on primarily in the CA2 region leads to altered social behaviors, Dr. Hepler noted. "This suggests that these mice may not forget things as easily as other mice, or perhaps they have altered social behavior or sensitivity to seizures. But not necessarily.”

Ms. Lee is investigating some of these probabilities now. "The pipe dream is that maybe you could find a compound that inhibits RGS14 or shuts it down,” she added. "Then, perhaps, you could enhance cognition.”

Related Links:

Emory University School of Medicine



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.